Michael Lehmann, executive vice president, global sales & marketing, Patheon shares his views on the challenges ahead for the pharma sector and how they could mean greater opportunities ahead for pharmaceutical manufacturers
Interestingly enough, the types of challenges facing biopharmaceutical companies in 2016, while not too different from previous years, are intensifying and point to greater opportunities for pharmaceutical development and manufacturing service providers.